TexAu
Company Profile

How Much Did Thirty Madison Raise? Headquarters, Funding & Key Investors

Founded in 2017 and headquartered in New York City, Thirty Madison is a virtual-first healthcare platform offering personalized treatment through brands like Keeps, Cove, Facet, Picnic, and NURX. The company has raised $210 million in total funding, reaching a $1 billion valuation in June 2021 after a $141 million Series C round. Backed by 137 Ventures and Bracket Capital, Thirty Madison focuses on making chronic care accessible through digital consultations and integrated treatment plans.

Thirty Madison joined the Unicorn Club on June 8, 2021, after achieving a $1 billion valuation. The company, based in New York City, United States, has developed a virtual-first healthcare platform that offers personalized treatments across a suite of specialized brands focused on chronic and long-term conditions.

Keep reading to learn how Thirty Madison redefined patient-centric care through telemedicine and personalized treatment programs for chronic health needs.

What Is Thirty Madison and What Does It Do?

Founded in 2017, Thirty Madison is a virtual healthcare platform that provides tailored treatment and care for chronic and specialty health conditions. Its brand portfolio includes Keeps for men’s hair loss, Cove for migraine management, Picnic for allergies, Facet for skin conditions, and NURX for sexual and reproductive health.

The platform’s model combines online consultations, ongoing care management, and medication delivery, empowering patients to manage conditions from home with medical oversight. By merging convenience, affordability, and clinical expertise, Thirty Madison has built a loyal patient community across the United States.

How Much Funding Has Thirty Madison Raised?

1. Series C Round

  • Amount Raised: $141 million
  • Date: June 2, 2021
  • Valuation: ~$1 billion
  • Lead Investors: HealthQuest Capital, Mousse Partners
  • Purpose: Expand into new healthcare verticals and scale telehealth capabilities

2. Earlier Rounds (Seed to Series B)

  • Cumulative Funding: ~$69 million
  • Key Investors: 137 Ventures, Bracket Capital, Polaris Partners
  • Purpose: Brand development, patient acquisition, and infrastructure scaling

Total Funding Raised: ~$210 million

Latest Funding Date: June 2, 2021

Last Known Valuation: ~$1 billion

Employee Count: 201–500 (as of July 16, 2025)

Key Investors

1. 137 Ventures

  • Details: Growth investment firm backing late-stage startups in healthcare and technology.
  • Focus Areas: Telemedicine, data-driven healthcare, and patient-centric platforms.

2. Bracket Capital

  • Details: Venture capital firm investing in technology-enabled consumer and healthcare businesses.
  • Focus Areas: Healthtech, fintech, and digital marketplaces.

Where Is Thirty Madison’s Headquarters?

Thirty Madison is headquartered in New York City, United States. Its distributed workforce supports virtual healthcare operations, clinical partnerships, and brand management across multiple U.S. states.

What’s Next for Thirty Madison?

Following its merger with NURX, Thirty Madison continues expanding its integrated care ecosystem, focusing on scalable virtual treatment programs. The company aims to personalize healthcare journeys through AI-driven diagnostics, teleconsultations, and medication management, ensuring accessible care for patients across chronic and long-term health categories.

Get Investor & Funding Insights with TexAu

TexAu helps you track verified funding and investor insights for companies like Thirty Madison. Stay informed about the latest developments in digital health and telemedicine innovation shaping the global healthcare landscape.

Sign up for Free on TexAu to explore investor data and funding trends across healthcare startups.

See your first enriched leads in 2 minutes

No credit card. No onboarding call. Just paste your list and watch it fill.

Up and running in 2 minutes. No credit card required.